Kirill Alexeyevich Breskin

Dr. Kirill Alexeyevich Breskin


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2023 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
KBKirill Alexeyevich Breskin
Kirill Alexeyevich Breskin
ЕРЕлена Розанова
Елена Розанова
VZVladimir M. Zhmykhov
Vladimir M. Zhmykhov
Екатерина БартеневаЕкатерина Бартенева
Екатерина Бартенева
This study is dedicated to an investigation and comparison of the kinetics of the foam stability of protein foaming agents based on the hydrolysates of solid keratin. The work utilized ready-made hydrolysates based on sodium hydroxide and a mixture of sodium hydroxide with calcium hydroxide for the synthesis of foaming agents. The synthesis was carried out according to the author’s methodology. Among the indicators studied were foam multiplication, foam specific weight, foam stability over time, and average foam stability reduction rate. Experiments were conducted with various concentrations and ratios of components at constant temperature, pressure, and pH values, as well as mixing speed, mixing time, and observation time. Itis hypothesized that protein foaming agents based on hydrolysates of solid keratin using a mixture of hydroxides will not be able to achieve optimal values in the kinetics of foam stability. In contrast, protein foaming agents based on hydrolysates of solid keratin using sodium hydroxide individually have high potential foaming properties and, consequently, good foam stability kinetics indicators. The results of this study may be useful in the development of new synthesis methods for protein foaming agents with optimal foaming properties or for improving those that already exist. The research itself and the products obtained during it—protein foaming agents—are mainly aimed at expanding the industrial sphere of human activity. This may also have practical applications in other areas, such as the food industry, cosmetology, medicine, and others.

2 November 2023 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
PAPavel Y. Andreev
Pavel Y. Andreev
Екатерина БартеневаЕкатерина Бартенева
Екатерина Бартенева
EGElena V. Grekhneva
Elena V. Grekhneva
KEKirill S. Efanov
Kirill S. Efanov
KBKirill Alexeyevich Breskin
Kirill Alexeyevich Breskin
One of the key characteristics of pharmaceutical substances is their solubility in pharmaceutically relevant media. This characteristic reflects the quality of the drug and the rate at which the pharmaceutical substance is released from its dosage form. Reduced efficacy and difficulties in the medical use of pharmaceutical substances are often associated with their low solubility in aqueous solutions. It is worth noting that about 40% of pharmaceuticals are practically insoluble, given that 85% are intended for oral administration, which is the simplest and most convenient form. The encapsulation of drug substances can solve this problem. The modern pharmaceutical industry uses molecular containers such as cyclodextrins for this purpose. The incorporation of the target component occurs on a host–guest basis and is driven by weak intermolecular interactions, the nature of which is not yet fully understood. Encapsulation has been shown to promote stability during storage, improve palatability, enhance pharmacological activity and bioavailability, reduce side effects, and, most importantly, increase the solubility of these substances. Our study presents the synthesis of the nimesulide inclusion complex in β-, γ-cyclodextrin cavity. The experimental results were confirmed using TLC, HPLC, UV- and IR spectroscopy, and X-ray diffraction analysis. The theoretical justification of the stability of the β-cyclodextrin/nimesulide complex was performed via one of the most innovative methods, the molecular dynamics method, using NAMD V2.14 and Gaussian 09W software with a simulation step of 2 femtoseconds and a duration of 5 nanoseconds. A modified CHARMM36 force field was used as the MD force field. The ability to enhance drug solubility and maintain drug stability is a promising area in the field of pharmaceutical chemistry.